Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Jun
14
2024
NNI EHS Research Strategy: 2024 Update Available for Public Comment Bergeson & Campbell, P.C.
Jun
14
2024
Supreme Court Rejects Challenge to FDA Approval of Mifepristone on Standing, but the Battle Continues Epstein Becker & Green, P.C.
Jun
14
2024
Client Alert: IARC to Evaluate Automotive Gasoline and Oxygenated Additives in Early 2025 Nelson Mullins
Jun
14
2024
Bump Stock Ruling May Presage Loper—and Clearer Answers to Immigration and Bankruptcy Questions - SCOTUS Today Epstein Becker & Green, P.C.
Jun
14
2024
McDermottPlus Check-Up: June 14, 2024 McDermott Will & Emery
Jun
14
2024
Supreme Court Unanimously Preserves Access to Mifepristone Sheppard, Mullin, Richter & Hampton LLP
Jun
14
2024
Deadline to Register Cosmetic Facilities and List Cosmetic Products Fast Approaches ArentFox Schiff LLP
Jun
13
2024
FDA Wins Mifepristone Case, NLRB Denied Lower Injunctive Relief Standards, and “Trump Too Small” Denied Trademark - SCOTUS Today Epstein Becker & Green, P.C.
Jun
13
2024
Kroger Faces Civil Lawsuit Over Calorie Claims on Bread Products Keller and Heckman LLP
Jun
13
2024
Supreme Court Rejects Challenge to FDA Approval of Mifepristone: Impact on Health Plans Proskauer Rose LLP
Jun
13
2024
New Jersey Takes a “Trip” Towards Therapeutic Psilocybin: Just Don’t Pack Your Bags Yet! Norris McLaughlin P.A.
Jun
13
2024
Registration Opens for June 27, 2024, NNI Webinar on “What’s Next in NanoEHS: Risk Assessment and Risk Management” Bergeson & Campbell, P.C.
Jun
12
2024
EPA Finalizes Risk Management Rules for Asbestos and Methylene Chloride Hunton Andrews Kurth
Jun
12
2024
Nothing Fishy About Whole Foods’ Fish Oil Supplement Product Label Proskauer Rose LLP
Jun
12
2024
Making Sense of a Rare Robinson-Patman Act Plaintiffs’ Verdict McDermott Will & Emery
Jun
12
2024
FDA to Implement Reorganization of Human Foods Program by October 1 Keller and Heckman LLP
Jun
11
2024
BIPA Amendments + FTC Warns Automakers Blank Rome LLP
Jun
11
2024
Remote Patient Monitoring Innovating Health Tech: A Discussion with Dr. Vipul Kella Sheppard, Mullin, Richter & Hampton LLP
Jun
11
2024
FDA Draft Guidance for Bioresearch Monitoring Program Contains General Best Practices for FDA Inspections Greenberg Traurig, LLP
Jun
11
2024
Consumer Reports Finds High Lead Levels in Snacks for Young Children Keller and Heckman LLP
Jun
11
2024
Da Brat and The Latest (Rap) Battle: FDA Expected to Drop Sperm Donation Ban for Gay Men ArentFox Schiff LLP
Jun
10
2024
CODEX ALIMENTARIUS: Outcome of 17th Codex Committee on Toxins and Contaminants in Foods (CCCF17) Keller and Heckman LLP
Jun
10
2024
CODEX ALIMENTARIUS: Outcome of 54th Codex Committee on Food Hygiene (CCFH54) Keller and Heckman LLP
Jun
6
2024
LDT Final Rule Series: Part 1 – Rule Overview Sheppard, Mullin, Richter & Hampton LLP
Jun
6
2024
LDT Final Rule Series: Part 2 – Response to the Rule Sheppard, Mullin, Richter & Hampton LLP
Jun
6
2024
Federal Circuit Upholds Rifaximin Patent Rulings, Affirms ANDA Approval Restrictions Sheppard, Mullin, Richter & Hampton LLP
Jun
6
2024
For Statutory Equivalents, Even One Means May Be Enough McDermott Will & Emery
Jun
6
2024
FDA Shares Findings from Multi-Year Pathogen Study Keller and Heckman LLP
Jun
5
2024
Switching Data – A Potent Tonic for Obtaining CMA Clearance at Phase 1 Squire Patton Boggs (US) LLP
Jun
5
2024
NIOSH Science Blog Item Reviews NIOSH Risk Assessment of Engineered Nanomaterials Bergeson & Campbell, P.C.
Jun
5
2024
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates Foley & Lardner LLP
Jun
5
2024
APHIS Issues RSR Responses for Modified Corn, Pennycress, Soybean, and Potato Plants Bergeson & Campbell, P.C.
Jun
5
2024
This Week in 340B: May 28 – June 3, 2024 McDermott Will & Emery
Jun
5
2024
Proposed Cannabis Reschedule Sidesteps State Law Effects Wilson Elser Moskowitz Edelman & Dicker LLP
Jun
5
2024
Illinois Legislature Passes Amendment to BIPA to Respond to Plaintiff-Friendly Decisions by Illinois Supreme Court Wilson Elser Moskowitz Edelman & Dicker LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins